Company Analysis JD Health International Inc.
1. Summary
Advantages
- Price (3.13 $) is less than fair price (5.63 $)
Disadvantages
- Dividends (0%) are below the sector average (1.76%).
- The stock's return over the last year (-37.5%) is lower than the sector average (-7.41%).
- Current debt level 0.3411% has increased over 5 years from 0.1256%.
- The company's current efficiency (ROE=4.34%) is lower than the sector average (ROE=13.23%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| JD Health International Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 0.2% | 0.7% |
| 90 days | 0% | -7.3% | 2.6% |
| 1 year | -37.5% | -7.4% | 25.8% |
JDHIF vs Sector: JD Health International Inc. has significantly underperformed the "Healthcare" sector by -30.09% over the past year.
JDHIF vs Market: JD Health International Inc. has significantly underperformed the market by -63.28% over the past year.
Stable price: JDHIF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: JDHIF with weekly volatility of -0.7212% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (3.13 $) is lower than the fair price (5.63 $).
Price significantly below the fair price: The current price (3.13 $) is 79.9% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (48.75) is higher than that of the sector as a whole (31.94).
P/E vs Market: The company's P/E (48.75) is higher than that of the market as a whole (46.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.12) is lower than that of the sector as a whole (3.37).
P/BV vs Market: The company's P/BV (2.12) is higher than that of the market as a whole (-9.04).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.95) is lower than that of the sector as a whole (3.27).
P/S vs Market: The company's P/S indicator (1.95) is lower than that of the market as a whole (4.84).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (104.38) is higher than that of the sector as a whole (10.05).
EV/Ebitda vs Market: The company's EV/Ebitda (104.38) is higher than that of the market as a whole (25.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -22.49% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-22.49%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (4.34%) is lower than that of the sector as a whole (13.23%).
ROE vs Market: The company's ROE (4.34%) is higher than that of the market as a whole (-8.19%).
5.5. ROA
ROA vs Sector: The company's ROA (3.33%) is lower than that of the sector as a whole (6.16%).
ROA vs Market: The company's ROA (3.33%) is lower than that of the market as a whole (4.87%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.76%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
